Dr. Immanuel Lerner, CEO and co-founder of Pepticom, will speak at the TIDES Asia conference between March 7-9. His lecture will be about The Potential and Current Application of Artificial Intelligence in Peptide Drug Discovery.
The conference will take place in Kyoto, from March 7-9, and he will be available for meetings there as well as in Tokyo on the 10th.